Molteni Farmaceutici, with its products distributed in more than 25 countries, has three head offices: Florence, Milan and Krakow (Poland).
The main production site is in Scandicci, in the province of Florence: a modern, 10,000 m2 facility, supplied with innovative technological and scientific equipment allowing cutting-edge quality and production volumes.
The production plant manufactures sterile injectable vials, oral vials, syrups and gels, with a capacity of over 7 million bottles of syrup per year and over 20 million vials per year. It employs about 250 highly-specialized workers, 40% of them involved in production and 10% in research and development (mainly young and female staff); the company’s yearly turnover is over 60 million Euro, with a yearly growth rate of 16% over the past two financial years, and a 60/40 subdivision between the hospital and public market. Foreign sales account for about 20% of the total. The goal is to improve investments to increase production capacity and expand the company’s presence on the market.
Krakow (Poland) – Molteni Farmaceutici Polonia was founded in 1994 in Krakow and is the company’s first investment abroad: an excellent starting point for expansion into North-East Europe. In 1995, thanks to pharmaceutical wholesale trading, Molteni Farmaceutici Polonia’s portfolio included the whole range of products developed by Molteni Farmaceutici. The following year, Molteni Farmaceutici Polonia acquired the status of manufacturer.
Currently, Molteni Farmaceutici Polonia is developing its activity in two main areas. The first and fastest-growing is the marketing of products related to dental anesthesia. Equally important and appreciated is its commitment to replacement therapy in opioid addiction. Molteni Farmaceutici Polonia actively attends conferences of the Polish Society for the Study of Pain and the Polish Association of Palliative Medicine.